Recent advances on the pathogenesis of Huntington's disease.
We review recent advances regarding the pathogenesis of Huntington's disease (HD). This genetic neurodegenerative disorder is caused by an expanded CAG repeat in a gene coding for a protein, with unknown function, called huntingtin. There is selective death of striatal and cortical neurons. Both in patients and a transgenic mouse model of the disease, neuronal intranuclear inclusions, immunoreactive for huntingtin and ubiquitin, develop. Huntingtin interacts with the proteins GAPDH, HAP-1, HIP1, HIP2, and calmodulin, and a mutant huntingtin is specifically cleaved by the proapoptotic enzyme caspase 3. The pathogenetic mechanism is not known, but it is presumed that there is a toxic gain of function of the mutant huntingtin. Circumstantial evidence suggests that excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis play a role.
Petersén
A
A
Department of Physiological Sciences, Wallenberg Neuroscience Center, Sölvegatan 17, Lund, 222 52, Sweden.
Mani
K
K
Brundin
P
P
D000818:Animals; D006801:Humans; D006816:Huntington Disease / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008959:Models, Neurological; D009462:Neurology / Q000639:trends*